Tarun Sai Lomte

MSc Biotechnology

Tarun is a writer based in Hyderabad, India. He has a Master’s degree in Biotechnology from the University of Hyderabad and is enthusiastic about scientific research. He enjoys reading research papers and literature reviews and is passionate about writing. During his Master’s, he developed an interest in Developmental Biology, Genetic Engineering, Immunology, and Bioinformatics and is keen on understanding the present-day developments in these domains. He has worked on molecular modeling, docking, and simulations for his Master’s thesis and cherishes the time spent in his academic life, especially the in-lab experience with his peers and instructors.

As a Bachelor’s student, he went on several field visits to different scientific laboratories researching fundamental and applied sciences which inspired him to pursue higher studies. He was also very involved in several academic activities such as science quizzes, presentations, and discussions. Besides life sciences, he is intrigued about the cosmos and follows the latest developments made in Astronomy by different space agencies. In his free time, Tarun enjoys traveling and watching cricket with a particular interest in the test format of the game. He likes watching movies and web series based on Sci-Fi, Fantasy, and Drama genres.

See less

Articles from Tarun

Digging into the past: What ancient proteins say about real medieval meals

Researchers used stable isotope and proteomic analyses on medieval European skeletons to uncover the details of ancient diets. The findings revealed a heavy reliance on C3 plants, terrestrial animal proteins, legumes, and freshwater fish, demonstrating the power of combining methods for paleodietary reconstruction.

24 Jul 2025

Fad diets and supplements fuel new wave of hidden skin problems, study finds

A new review explains how fad diets and unregulated supplements promoted online can cause serious skin, hair, and nail problems, often before other symptoms appear. Clinicians are urged to recognize these risks and address health misinformation in the digital age.

22 Jul 2025

Blocking a single gene disrupts vitamin D metabolism and cancer pathways in new cell study

Researchers identified SDR42E1 as a key regulator of vitamin D absorption and sterol metabolism in colorectal cancer cells. Disruption of this enzyme altered cancer-related pathways and cell viability, highlighting its potential as a therapeutic target.

21 Jul 2025

APOE ε4 variant reveals hidden risk factors beyond Alzheimer’s

Researchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across their blood, brain, and cerebrospinal fluid—regardless of neurodegenerative disease diagnosis. This signature reveals a fundamental, disease-independent vulnerability linked to APOE ε4, reframing our understanding of genetic risk in conditions like Alzheimer's, Parkinson’s, ALS, and FTD.

21 Jul 2025

Allergies linked to lower lung cancer risk, new study finds

A meta-analysis of nearly 3.9 million participants shows people with allergies have significantly lower odds of developing lung cancer. Allergic rhinitis is particularly protective, while eczema’s effect appears limited to men.

20 Jul 2025

Blocking GAPDH aggregation protects brain cells and opens new path for stroke therapy

In a mouse model of acute ischemic stroke, researchers showed that inhibiting the aggregation of GAPDH, either genetically or with a novel peptide, significantly reduced brain damage and improved neurological function. The findings highlight GAPDH aggregation as a promising therapeutic target for stroke intervention.

20 Jul 2025

Boosting gut-friendly foods may slow biological aging, large US study finds

Higher scores on a dietary index linked to gut microbiota health are associated with slower biological aging in US adults, according to a large cross-sectional NHANES study. The findings suggest that improving diet quality for gut microbial diversity may help reduce age-related disease risk.

20 Jul 2025

New nanobody-liposome combo stops lung cancer growth and delivers targeted chemotherapy

Researchers engineered a nanobody-conjugated liposome (A5-LNP-DOX) that targets CD155 and delivers doxorubicin directly to lung adenocarcinoma cells, dramatically suppressing tumor growth in preclinical models. This approach not only inhibited cancer cell migration and invasion but also showed strong potential for safer, more precise lung cancer therapy.

14 Jul 2025

Is fruit juice good or bad for diabetes? New research reveals a genetic twist

Japanese adults with a high genetic risk for type 2 diabetes who consumed 100% fruit juice at least once per week had significantly lower odds of developing the disease. The inverse association was not seen in people with low or moderate genetic risk, highlighting gene-diet interactions.

13 Jul 2025

TMP-SMX in early pregnancy increases risk of birth defects, new study shows

A large US cohort study found that using trimethoprim-sulfamethoxazole (TMP-SMX) for UTI in the first trimester of pregnancy was associated with a higher risk of congenital malformations compared to β-lactam antibiotics. No increased risk was seen with nitrofurantoin or fluoroquinolones.

10 Jul 2025